Clinical Trial Update: Azacytidine and Lymphocytes in Relapse of AML or MDS After Allogeneic Stem Cell Transplantation. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating azacytidine and lymphocytes in relapse of acute myeloid leukemia or myelodysplastic syndrome after allogeneic stem cell transp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• azacytidine (azacitidine)

Snippet

Sponsor: Carlos Graux, MD, PhD | Conditions: Acute Myelogenous Leukemia, Myelodysplastic Syndrome | Phase 2 | Status: COMPLETED